中国肺癌杂志2012，Vol.15Issue(1)：39-43,5.DOI:10.3779/j.issn.1009-3419.2012.01.08
肺癌术后支气管胸膜瘘致死性大咯血经验(附7例报告)
Clinical Experiences of Bronchopleural Fistula-related Fatal Hemoptysis after the Resection of Lung Cancer: A Report of 7 Cases
张真铭 1王允1
作者信息
- 1. 610041成都,四川大学华西医院胸外科
- 折叠
摘要
Abstract
Background and objective Massive hemoptysis was a rare but severe postoperative complication of lung cancer. The aim of the present study is to investigate the mechanisms, risk factors, early symptoms, prevention, and treatment options for fatal hemoptysis. Methods From April 2007 to May 2011, 1,737 patients with lung cancer were surgically treated in the West China Hospital of Sichuan University. Twenty patients died during the perioperative period, seven of whom died of massive hemoptysis. These seven cases were analyzed, and their clinical data, as well as related literatures, were reviewed. Results Massive hemoptysis is the second cause of death after lung cancer surgery. Six patients died directly of massive hemoptysis. One patient underwent secondary surgery because of massive hemoptysis, but eventually died because of lung infection and respiratory failure. Early symptoms of hemorrhage were observed in four cases, and the overall incidence rate of massive hemoptysis was 0.4% (7/1,737). Conclusion Bronchovascular fistula (BVF) caused by bronchopleural fistula (BPF) is the mechanism for massive hemoptysis. Diabetes is a high risk factor. Early diagnosis and surgical treatment of BPF or BVF can prevent the occurrence of death as a result of massive hemoptysis.关键词
肺肿瘤/支气管胸膜瘘/支气管血管瘘/咯血Key words
Lung neoplasms/ Bronchopleural fistula/ Bronchovascular fistula/ Hemoptysis分类
医药卫生引用本文复制引用
张真铭,王允..肺癌术后支气管胸膜瘘致死性大咯血经验(附7例报告)[J].中国肺癌杂志,2012,15(1):39-43,5.
